← Explorer/Network

Neurologic manifestations of Lyme disease, the new “Great Imitator”

Pachner AR1989Clinical Infectious DiseasesJournal Article
10.1093/clinids/11.supplement_6.s1482PubMed
Immune/InnateNeurological
Lyme & Co-Infections

Abstract

The causative agent of Lyme disease, Borrelia burgdorferi, is a highly neurotropic organism that not only can produce symptomatic neurologic disease but also can exist dormant within the central nervous system (CNS) for long periods. Two distinct types of neuroborreliosis occur at different stages of Lyme disease. Second-stage Lyme meningitis resembles aseptic meningitis and is often associated with facial palsies, peripheral nerve involvement, and/or radiculopathies. Lyme meningitis may be the first evidence of Lyme disease, occurring without a history of erythema chronicum migrans or flu-like illness. Third-stage parenchymal involvement causes a multitude of nonspecific CNS manifestations that can be confused with conditions such as multiple sclerosis, brain tumor, and psychiatric derangements. Manifestations of CNS parenchymal involvement in Lyme disease are generally associated, however, with a history of erythema chronicum migrans, meningitis, or carditis. Both second- and third-stage Lyme neuroborrelioses are commonly misdiagnosed because they are relatively uncommon and because they mimic many better-known disorders.

Cited By (5)

  • Lyme disease: A neuropsychiatric illnessAmerican Journal of Psychiatry · 1994
  • The underdiagnosis of neuropsychiatric Lyme disease in children and adultsPsychiatric Clinics of North America · 1998
  • Inoculation of nonhuman primates with the N40 strain of Borrelia burgdorferi leads to a model of Lyme neuroborreliosis faithful to the human diseaseNeurology · 1995
  • Late-Stage Neuropsychiatric Lyme BorreliosisPsychosomatics · 1995
  • Delirium and Lyme DiseasePsychosomatics · 1995

References (7)

  • The early clinical manifestations of Lyme diseaseAnnals of Internal Medicine · 1983
  • Progressive Borrelien-Enzephalomyelitis: Chronische Manifestation der Erythema-chronicum-migrans-Krankheit am Nervensystem

Related Papers

  • Herbal Therapeutics for CIRS Biomarkers in Autism Spectrum Disorders: A Mechanistic and Molecular Approach for Neuroimmune Pathology in PediatricsMedical Research Archives · 2025 · 3 shared tags
  • Exploring Structured Camel Milk Therapy Alongside an Individualised Botanical Support Protocol to Facilitate Immune Modulation in a Child Diagnosed with PANS/PANDAS Co-Morbid with Lyme Disease and AutismJournal of Camel Practice and Research · 2025 · 3 shared tags
  • Neuroplasticity Intervention, Amygdala and Insula Retraining (AIR), Significantly Improves Overall Health and Functioning Across Various Chronic Conditions.PubMed · 2023 · 3 shared tags
  • Introduction to Chronic Inflammatory Response Syndrome (CIRS)2023 · 3 shared tags
  • TUBB1, TUBA4A and MAPK as Indicators of Die-Back Degenerative Central Nervous System Disease in Patients Sickened by Specific Exposure to the Interior Environment of Water- Damaged BuildingsMedical Research Archives · 2023 · 3 shared tags
  • Autism Spectrum Disorders and Lyme Disease: Exploring Shared Neuro-Inflammatory and Immune Pathways
DMW - Deutsche Medizinische Wochenschrift · 1985
  • Demyelinating encephalopathy in Lyme diseaseNeurology · 1985
  • Neurologic abnormalities in Lyme disease without erythema chronicum migransThe American Journal of Medicine · 1986
  • The triad of neurologic manifestations of Lyme diseaseNeurology · 1985
  • Neurologic Abnormalities of Lyme Disease: Successful Treatment with High-Dose Intravenous PenicillinAnnals of Internal Medicine · 1983
  • Chronic progressive neurological involvement in Borrelia burgdorferi infectionJournal of Neurology · 1987
  • Medical Research Archives · 2025 · 3 shared tags